Knockout of EZH2 inhibits migration and invasion of human cervical cancer cell lines

doi:10.16352/j.issn.1001-6325.2022.03.004

Abstract

Abstract: Objective To explore the effect of EZH2 on the migration and invasion of human cervical cancer cell lines and its mechanism. Methods CRISPR/Cas9 was used to knockout EZH2 expression in HeLa and SiHa cell lines. The migration was detected by scratch test, and the migration and invasion in vitro was detected by Transwell migration and invasion test. The STAT3 mRNA level was detected by real-time fluorescence quantitative PCR, and the expression of STAT3 and p-STAT3 proteins was detected by Western blot. Results CRISPR/Cas9 could knockout EZH2 expression. The wound healing rate of HeLa and SiHa cells in EZH2 knockout group at 24 h and 48 h, and the counting of transmembrane cell migration and invasion in Transwell chamber were lower than those in control group(P＜0.05). Compared with the control group, the protein level of p-STAT3 in EZH2 knockout group was significantly decreased (P＜0.05). Conclusions EZH2 plays an important role in promoting the migration and invasion of cervical cancer cells, which may be related to the targeted regulation of STAT3 pathway, and is a potential target in the treatment of cervical cancer.

Key words: cervical cancer, EZH2, migration and invasion, STAT3 signaling pathway

CLC Number:

R737.33

CHEN Qian, LIU Xian, CUI Nan, ZHAI Yang. Knockout of EZH2 inhibits migration and invasion of human cervical cancer cell lines[J]. Basic & Clinical Medicine, 2022, 42(3): 395-400.

References

[1]Siegel RL,Miller KD,Jemal A.Cancer statistics, 2018[J].CA Cancer J Clin,2018,68:7-30.
[2]Venneti S,Garimella MT,Sullivan LM,et al.Evaluation of Histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas[J].Brain Pathol,2013,23:558-564.
[3]Italiano A.Role of the EZH2 histone methyltransferase as a therapeutic target in cancer[J].Pharmacol Ther,2016,165:26-31.
[4]Wen Y,Jing C,Hou Y,et al. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target[J].Oncotarget,2017,8:37974-37990.
[5]Chen Q,Zheng PS,Yang WT.EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma[J]. Oncotarget,2016,7:36115-36129.
[6]Chen YH,Yang SF,Yang CK,et al. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells[J].Mol Med Rep,2021.doi:10.3892/mmr.2020.11725.
[7]Zhou L,Mudianto T, Ma X, et al. Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti-PD-1 resistance in head and neck cancer[J].Clin Cancer Res,2020,26: 290-300.
[8]Lachat C,D Bruyère,Etcheverry A,et al. EZH2 and KDM6B expressions are associated with specific epigenetic signatures during EMT in non small cell lung carcinomas[J].Cancers,2020,12:3649. doi: 10.3390/cancers12123649.
[9]Chien YC,Liu LC,Ye HY,et al. EZH2 promotes migration and invasion of triple-negative breast cancer cells via regulating TIMP2-MMP-2/-9 pathway.[J].Am J Cancer Res,2018,8:422-434.
[10]Xu SG,Yu JJ,Shi Q,et al. Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion[J]. Oncol Rep,2019,42:273-282.
[11]Chen XQ,Lv XY,Liu SJ. Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by regulating intestinal microbiota and the IL-6/STAT3 signaling pathway[J].J Ethnopharmacol,2021,265:113357.doi: 10.1016/j.jep.2020.113357.
[12]张锦锦,唐慧.JAK/STAT3信号通路调控肿瘤及其相关生物功能的研究进展[J].基础医学与临床,2017,37:1456-1460.
[13]宋茜,黄雪,覃蒙斌,等.STAT3通路参与白细胞介素-22促进人结肠癌细胞系HT29紧密连接蛋白的表达[J].基础医学与临床,2021,6: 792-798.
[14]Chen Z, Du Y, Liu X,et al. EZH2 inhibition suppresses bladder cancer cell growth and metastasis via the JAK2/STAT3 signaling pathway[J]. Oncol Lett,2019, 18:907-915.
[15]Kim E, Kim M, Woo DH,et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells[J]. Cancer Cell,2013, 23:839-852.